ArticleMolecular oncology2023

PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.

Oxana V Denisova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.